Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-18022026-270264
EXTRAORDINARY
PART II—Section 3—Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 865]
NEW DELHI, WEDNESDAY, FEBRUARY 18, 2026/MAGHA 29, 1947
1253 GI/2026
MINISTRY OF FINANCE
(Department of Revenue)
NOTIFICATION
New Delhi, the 18th February, 2026
S.O. 905(E). In exercise of the powers conferred by sub-clause (b) of clause (xi) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares the following
substances, salts and preparations thereof to be manufactured drugs, namely: -
(i) N-Pyrrolidino protonitazene (protonitazepyne)-
2-[(4-Propoxyphenyl) methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzoimidazole;
(ii) N-pyrrolidino metonitazene (metonitazepyne)-
2-[(4-methoxyphenyl) methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzoimidazole;
(iii) Etonitazepipne (N-piperidinyl etonitazene)
2-[(4-Ethoxyphenyl) methyl]-5-nitro-1-(2-piperidin-1-ylethyl)-1H-benzoimidazole;
(iv) N-Desethyl-isotonitazene (norisotonitazene)
N-Ethyl-2-[[4-(1-methylethoxy) phenyl] methyl]-5-nitro-1H-benzimidazole-1-ethanamine.
2. This notification shall come into force from the date of its publication in the Official Gazette.
[F. No N-12019/1/2025-NC-II-DOR]
MUKESH SUNDRIYAL, Under Secy.
NOTIFICATION
New Delhi, the 18th February, 2026
S.O. 906(E).— WHEREAS the Central Government is satisfied, on the basis of information and evidence
which has become available to it, with respect to the nature and effects of, or the scope of abuse of the following
substances (natural or synthetic) or natural material or any salt or preparation of such substances or materials, and the
modification with respect to such substances and the changes that have been incorporated in the United Nations
Convention on Psychotropic Substances, 1971, and that it is necessary to add the following substances or natural
materials or salts or preparation of such substances or materials in the list of psychotropic substances specified in the
Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) (hereinafter referred to as the
said Act).
NOW, THEREFORE, in exercise of the powers conferred by section 3 of the said Act, the Central Government
hereby makes the following further amendments in the list of psychotropic substances specified in the Schedule to the
said Act, namely: -
In the said Act, in the Schedule, after serial number 110ZZI and the entries relating thereto, the following serial
numbers and entries shall, respectively be inserted, namely: -
+---------+-----------------------------------+-----------------------------+-------------------------------------------------------------+
| Sl. No. | International non-Proprietary | Other non-proprietary names | Chemical Name |
| | names | | |
+=========+===================================+=============================+=============================================================+
| "110ZZJ | | Hexahydrocannabinol (HHC) | 6,6,9-Trimethyl-3-pentyl- |
| | | | 6a,7,8,9,10,10a- |
| | | | hexahydrobenzo[c]chromen-1-ol |
+---------+-----------------------------------+-----------------------------+-------------------------------------------------------------+
| 110ZZK | | Carisoprodol | 2-[(carbamoyloxy)methyl]-2- |
| | | | methylpentyl(1- |
| | | | ethylethyl)carbamate" |
+---------+-----------------------------------+-----------------------------+-------------------------------------------------------------+
2. This notification shall come into force from the date of its publication in the Official Gazette.
[F. No N-12019/1/2025-NC-II-DOR]
MUKESH SUNDRIYAL, Under Secy.
Note: The Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) was first amended, vide
number S.O. 785(E), dated the 26th October, 1992 and subsequently amended, vide numbers S.O. 49(E), dated the
8th January, 1993, S.O. 39(E), dated the 12th January, 1996, S.O. 475(E), dated the 11th June, 2003, G.S.R. 621(E), dated
the 1st August, 2003, G.S.R. 1(E), dated the 2nd January, 2004, S.O. 311 (E), dated the 10th February, 2011, S.O. 376(E),
dated the 5th February, 2015, S.O. No. 2374 (E), dated the 12th July, 2016, S.O. No. 1383 (E), dated the 2nd May, 2017,
S.O. 821(E), dated the 27th February, 2018, S.O. 1761(E), dated the 26th April, 2018 and S.O. 3448(E) dated the 13th
July, 2018, S.O. 1352(E), dated the 13th March 2019, S.O. 1275(E), dated the 23rd March 2021, S.O. 4428(E), dated the
22nd September 2022, S.O. 5319 (E), dated the 16th November, 2022, S.O. 578(E), dated the 8th February, 2024 and
S.O. 1730(E) dated 16th April, 2025.
NOTIFICATION
New Delhi, the 18th February, 2026
S.O. 907(E). — In exercise of the powers conferred by clauses (viia) and (xxiia) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby makes the following further
amendments in the notification of the Government of India in the Ministry of Finance, Department of Revenue,
published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 1055 (E), dated
the 19th October, 2001, namely:-
In the said notification, in the Table, after serial number 238 ZZZL and the entries relating thereto, the following
serial numbers and entries shall, respectively be inserted, namely: -
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| S. No. | Name of Narcotic Drug and Psychotropic Substance (International | Other non-proprietary names | Chemical name | Small Quantity (in gm.) (Single dose in gm X | Commercial Quantity (in gm.) (Small quantity in gm X 50) |
| | non-proprietary names (INN)) | | | 100) | |
+==========+================================================================+=============================+=========================================================================+===============================================+===========================================+
| "238ZZZM | N-Pyrrolidino protonitazene (protonitazepyne) | | 2-[(4-Propoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H- | 0.0017gm | 0.085gm |
| | | | benzoimidazole | | |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| 238ZZZN | N-pyrrolidino metonitazene (metonitazepyne)- | | 2-[(4-methoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H- | 0.50gm | 25gm |
| | | | benzoimidazole | | |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| 238ZZZO | Etonitazepipne (N-piperidinyl etonitazene) | | 2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-piperidin-1-ylethyl)-1H- | 0.0075 gm | 0.375gm |
| | | | benzoimidazole | | |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| 238ZZZP | N-Desethyl-isotonitazene (Norisotonitazene) | | N-Ethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole- | 0.01gm | 0.5 gm |
| | | | 1-ethanamine | | |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| 238ZZZQ | | Hexahydrocannabinol (HHC) | 6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | 0.5gm | 25gm |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
| 238ZZZR | | Carisoprodol | 2-[(carbamoyloxy)methyl]-2-methylpentyl(1-ethylethyl)carbamate | 25 gm | 1250gm" |
+----------+----------------------------------------------------------------+-----------------------------+-------------------------------------------------------------------------+-----------------------------------------------+-------------------------------------------+
2. This notification shall come into force from the date of its publication in the Official Gazette.
[F. No N-12019/1/2025-NC-II-DOR]
MUKESH SUNDRIYAL, Under Secy.
Note: The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3,
Sub-section (ii), vide number S.O. 1055 (E), dated the 19th October, 2001 and subsequently amended vide numbers
S.O. 2941 (E), dated the 18th November, 2009, S.O. 1430 (E), dated the 21st June, 2011, S.O. 375 (E) dated the 5th
February, 2015, S.O. 2375(E), dated the 12th July, 2016, S.O. 384 (E), dated the 2nd May, 2017, S.O. 822(E), dated the
27th February, 2018, S.O. 1762(E), dated the 26th April, 2018, S.O. 1351 (E), dated the 13th March 2019, S.O. 1276 (Ε),
dated the 23rd March 2021, S.O. 4429 (E), dated the 22nd September 2022, S.O. 5320 (E), dated 16th November, 2022
S.O. 578(E), dated the 8th February, 2024 and S.O. 1731 (E) dated 16th April, 2025.